Abstract:Increasing evidences have indicated that only a phenotypic subset of cancer cells, termed as the cancer stem cells (CSCs), is capable of initiating tumor growth and provide a reservoir of cells that cause tumor recurrence after therapy. Epithelial–mesenchymal transition (EMT), a cell type change from an epithelial cobblestone phenotype to an elongated fibroblastic phenotype, plays a critical role not only in tumor metastasis but also in tumor recurrence and contributes to drug resistance. Accumulating evidence has shown that cells with an EMT phenotype are rich sources for CSCs, suggesting a biological link between EMT and CSCs; thus study on the link will help understand the cellular and molecular mechanisms of tumor metastasis and drug resistance. CD29 is involved in EMT through cross-talk with cadherins and CD44 has been reported as a successful used marker for CSCs. Here, we try to address whether combination of CD29 and CD44 could be used to identify cancer stem-like cells undergoing EMT in squamous cell carcinoma (SCC) and compare the molecular differences between CD29high/CD44high and CD29low/CD44low cells in SCC. Expression pattern of CD29 and CD44 was analyzed in tissues of skin SCC and cultured A431 cells by immunostaining. Subtype cells of CD29high/CD44high and CD29low/CD44low A431 were sorted by fluorescence-activated cell sorting and proliferating abilities were assayed by cell counting, colony forming and tumorigenicity in NOD/SCID mice. Finally, to probe more deeply into the molecular differences between CD29high/CD44high and CD29low/CD44low A431 cells, gene microarray analysis was applied to compare gene expression profiling. Staining of CD29 and CD44 showed similar heterogeneous expression pattern with positive cells located in the invasion front of SCC tissue as well as in cultured A431 cells. Sorted CD29high/CD44high A431 cells had higher proliferating ability in vitro and in NOD/SCID mice as compared with CD29low/CD44low cells. Gene profiling identified differentiated gene expressions between CD29high/CD44high and CD29low/CD44low A431 cells. These genes are involved in cell cycle, cell malignant transformation, metastasis, drug resistance and EMT, implying that CD29high/CD44high cells have properties of CSCs and EMT. Our present results demonstrated heterogeneous gene expression patterns and different biological behavior in SCC. Combination of CD29 and CD44 can be used as markers to enrich CSCs in human SCC. Moreover, CD29high/CD44high cells exhibit molecular characteristics of EMT, suggesting that CSC-associated pathways were involved in EMT. Studies on correlation of CSCs and the cells undergoing EMT may explain some aspects of tumor progression and drug resistance.

Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation.

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

CD44 3'-Untranslated Region Functions As a Competing Endogenous RNA to Enhance NK Sensitivity of Liver Cancer Stem Cell by Regulating ULBP2 Expression.

Cd133 Silencing Inhibits Sternness Properties And Enhances Chemoradiosensitivity In Cd133-Positive Liver Cancer Stern Cells

CD44v6+ Hepatocellular Carcinoma Cells Maintain Stemness Properties Through Met/cJun/Nanog Signaling

Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition

Musashi2 Contributes to the Maintenance of CD44v6+ Liver Cancer Stem Cells Via Notch1 Signaling Pathway.

Cancer Stem/Progenitor Cells Are Highly Enriched In Cd133(+)Cd44(+) Population In Hepatocellular Carcinoma

Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.

Nuclear Cd44 Mediated By Importin Beta Participated In Naive Genes Transcriptional Regulation In C3a-Icscs

Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinoma

Oct4 Regulates the Transition of Cancer Stem-Like Cells to Tumor Endothelial-Like Cells in Human Liver Cancer

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma.

The Power and the Promise of Liver Cancer Stem Cell Markers.

CD44 Potentiates Hepatocellular Carcinoma Migration and Extrahepatic Metastases Via the AKT/ERK Signaling CXCR4 Axis.

CD73 Sustained Cancer-Stem-cell Traits by Promoting SOX9 Expression and Stability in Hepatocellular Carcinoma

CD44 Promotes Cell Proliferation in Non-Small Cell Lung Cancer

Breast Cancer Stem Cells Expressing Different Stem Cell Markers Exhibit Distinct Biological Characteristics

Identification of gastric cancer stem cells using the cell surface marker CD44.

Cancer Stem-Like Cells Enriched with CD29 and CD44 Markers Exhibit Molecular Characteristics with Epithelial–mesenchymal Transition in Squamous Cell Carcinoma

Reduced CD146 Expression Promotes Tumorigenesis and Cancer Stemness in Colorectal Cancer Through Activating Wnt/β-catenin Signaling.